BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 27007854)

  • 21. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
    Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
    J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring agonist-promoted conformational changes of beta-arrestin in living cells by intramolecular BRET.
    Charest PG; Terrillon S; Bouvier M
    EMBO Rep; 2005 Apr; 6(4):334-40. PubMed ID: 15776020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential regulation of endosomal GPCR/β-arrestin complexes and trafficking by MAPK.
    Khoury E; Nikolajev L; Simaan M; Namkung Y; Laporte SA
    J Biol Chem; 2014 Aug; 289(34):23302-17. PubMed ID: 25016018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure of active β-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide.
    Shukla AK; Manglik A; Kruse AC; Xiao K; Reis RI; Tseng WC; Staus DP; Hilger D; Uysal S; Huang LY; Paduch M; Tripathi-Shukla P; Koide A; Koide S; Weis WI; Kossiakoff AA; Kobilka BK; Lefkowitz RJ
    Nature; 2013 May; 497(7447):137-41. PubMed ID: 23604254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noncanonical GPCR signaling arising from a PTH receptor-arrestin-Gβγ complex.
    Wehbi VL; Stevenson HP; Feinstein TN; Calero G; Romero G; Vilardaga JP
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1530-5. PubMed ID: 23297229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formyl peptide receptor-mediated ERK1/2 activation occurs through G(i) and is not dependent on beta-arrestin1/2.
    Gripentrog JM; Miettinen HM
    Cell Signal; 2008 Feb; 20(2):424-31. PubMed ID: 18060741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detailed analysis of biased histamine H₄ receptor signalling by JNJ 7777120 analogues.
    Nijmeijer S; Vischer HF; Sirci F; Schultes S; Engelhardt H; de Graaf C; Rosethorne EM; Charlton SJ; Leurs R
    Br J Pharmacol; 2013 Sep; 170(1):78-88. PubMed ID: 23351115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. β-Arrestin drives MAP kinase signalling from clathrin-coated structures after GPCR dissociation.
    Eichel K; Jullié D; von Zastrow M
    Nat Cell Biol; 2016 Mar; 18(3):303-10. PubMed ID: 26829388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-throughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based beta-arrestin2 recruitment assay.
    Hamdan FF; Audet M; Garneau P; Pelletier J; Bouvier M
    J Biomol Screen; 2005 Aug; 10(5):463-75. PubMed ID: 16093556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. beta -Arrestins regulate protease-activated receptor-1 desensitization but not internalization or Down-regulation.
    Paing MM; Stutts AB; Kohout TA; Lefkowitz RJ; Trejo J
    J Biol Chem; 2002 Jan; 277(2):1292-300. PubMed ID: 11694535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PKCβII inhibits the ubiquitination of β-arrestin2 in an autophosphorylation-dependent manner.
    Zheng M; Zhang X; Guo S; Zhang X; Choi HJ; Lee MY; Kim KM
    FEBS Lett; 2015 Dec; 589(24 Pt B):3929-37. PubMed ID: 26545496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constitutive ERK1/2 activation by a chimeric neurokinin 1 receptor-beta-arrestin1 fusion protein. Probing the composition and function of the G protein-coupled receptor "signalsome".
    Jafri F; El-Shewy HM; Lee MH; Kelly M; Luttrell DK; Luttrell LM
    J Biol Chem; 2006 Jul; 281(28):19346-57. PubMed ID: 16670094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes.
    Shenoy SK; Lefkowitz RJ
    J Biol Chem; 2005 Apr; 280(15):15315-24. PubMed ID: 15699045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring interactions between G-protein-coupled receptors and beta-arrestins.
    Pfleger KD; Dalrymple MB; Dromey JR; Eidne KA
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):764-6. PubMed ID: 17635143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
    Gripentrog JM; Miettinen HM
    Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling.
    Peterson YK; Luttrell LM
    Pharmacol Rev; 2017 Jul; 69(3):256-297. PubMed ID: 28626043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription.
    Lee MH; El-Shewy HM; Luttrell DK; Luttrell LM
    J Biol Chem; 2008 Jan; 283(4):2088-97. PubMed ID: 18006496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of beta-arrestins in the formyl peptide receptor-like 1 internalization and signaling.
    Huet E; Boulay F; Barral S; Rabiet MJ
    Cell Signal; 2007 Sep; 19(9):1939-48. PubMed ID: 17594911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-arrestin signaling and regulation of transcription.
    Ma L; Pei G
    J Cell Sci; 2007 Jan; 120(Pt 2):213-8. PubMed ID: 17215450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discrete GPCR-triggered endocytic modes enable β-arrestins to flexibly regulate cell signaling.
    Barsi-Rhyne B; Manglik A; von Zastrow M
    Elife; 2022 Oct; 11():. PubMed ID: 36250629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.